Natural surfactant for prevention and treatment of RDS
Phospholipid fraction from bovine lungs.
Prevention of respiratory distress syndrome (RDS) in premature infants.
Treatment of infantile respiratory distress syndrome (RDS).
Pharmaceutical form and presentations
Lyophilized phospholipids in vials with 50 mg and 100 mg.
Syringe with solvent for reconstitution.
Storage at room temperature.
Regulatory status, indications and product information may vary from country to country.
Product descriptions provide basic information and are not usage instructions.
Please observe the officially approved product information.